SOTIO
LIVE

Serial Number

79218559

Owner

Sotio Biotech a.s

Attorney

Shane Rumbaugh

Filing Date

Aug 10, 2017

Add to watchlist:

No watchlists yet
View on USPTO

SOTIO Trademark

Serial Number: 79218559 • Registration: 5577770

SOTIO is a trademark filed by Sotio Biotech a.s on August 10, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Sotio Biotech a.s (5 trademarks)

Jankovcova 1518/2
Prague 7 CZ-170 00 , CZ

Entity Type: 99

SOTIO a.s. (6 trademarks)

Prague 7 CZ-17000 , CZ

Entity Type: 09

Trademark Details

Filing Date

August 10, 2017

Registration Date

October 9, 2018

Published for Opposition

July 24, 2018

Goods & Services

Medical services; medical diagnostic services for diagnostic or treatment purposes

Pharmaceuticals, [ medical and veterinary ] preparations for the treatment of oncological, [ immune and autoimmune ] diseases; anticancer preparations; antitumor drugs; [ vaccines; anticancer vaccines; synthetic peptides, recombinant proteins, antibodies, antibody derivatives, antibody-drug conjugates, nucleotides and nucleotide analogs all for the treatment of oncological, immune and autoimmune diseases for medical and veterinary purposes; ] biological preparations for the treatment of oncological, [ immune and autoimmune ] diseases for medical [ and veterinary ] purposes; cellular preparations for the treatment of oncological [ , immune and autoimmune ] diseases for medical [ and veterinary ] purposes [ ; biological tissue from blood or bone marrow intended for subsequent implantation; radiopharmaceutical preparations for diagnostic, medical and veterinary use; pharmaceutical preparations for the treatment of autoimmune diseases and diabetes; clinical diagnostic reagents for medical or veterinary purposes; diagnostic agents, preparations and diagnostic kits comprised of medical diagnostic reagents, sample collection devices in the nature of specimen cups and tubes, and instructions for testing of bodily fluids and tissues for use in testing and detection of oncological, immune or autoimmune diseases for medical and veterinary purposes; drug delivery agents in the form of dissolvable tablets, capsules, gels, micelles, liposomes, particles, nanoparticles, ointment and creams, that facilitate the delivery of pharmaceutical preparations; adjuvants for medical use; dietetic substances adapted for medical use, namely, food and beverages ]

Scientific services, namely, research and design in the field of antineoplastic and immunomudulating agents relating thereto; industrial analysis and research services in the field of pharmaceuticals and biotechnology; scientific research for medical [ and veterinary ] purposes in the field of oncological, [ immune and autoimmune ] diseases ; scientific research and development for medical [ and veterinary ] purposes in the area of cancerous diseases, [ autoimmune diseases or diabetes; ] pharmaceutical drug development services; conducting clinical trials for others; preclinical and clinical research in the field of oncological [ , immune and autoimmune ] diseases; analysis of toxicology and mode of action of biologicals, chemicals and combinations on animals, namely, toxicology services; pharmaceutical and biological product research, development, safety, efficacy and quality control testing services; scientific research and development for diagnostic purposes [ ; computer-aided diagnostic testing services, namely, providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; design and development of computer software and databases; design and development of computer software and databases for logistics, supply chain management and laboratory management in the fields of oncology and autoimmune disease and cancer and autoimmune research ]

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 18, 2026 INPR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 5, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 5, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 5, 2025 REAP
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jul 18, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Jul 18, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 14, 2025 APRE
TEAS SECTION 71 RECEIVED
Apr 9, 2025 ES71
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 16, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 16, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 16, 2024 REAP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 9, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Nov 18, 2022 NREP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 20, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 20, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 20, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 20, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 20, 2022 COAR
CHANGE OF OWNER RECEIVED FROM IB
Feb 11, 2022 CHLD
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 3, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 3, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 3, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 3, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 3, 2021 COAR
NEW REPRESENTATIVE AT IB RECEIVED
May 21, 2020 NREP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 18, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 18, 2019 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 15, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 24, 2019 FICS
FINAL DISPOSITION PROCESSED
Jan 24, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 9, 2019 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Dec 27, 2018 NREP
REGISTERED-PRINCIPAL REGISTER
Oct 9, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 24, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jul 24, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Jul 20, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 4, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 4, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 4, 2018 OP2R
NEW REPRESENTATIVE AT IB RECEIVED
Jun 21, 2018 NREP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 15, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 15, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 15, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 15, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 15, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 6, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 6, 2018 CRFA
ASSIGNED TO LIE
Jun 1, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 29, 2018 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 22, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 22, 2018 REAP
REFUSAL PROCESSED BY IB
Dec 17, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 27, 2017 RFCS
REFUSAL PROCESSED BY MPU
Nov 27, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 14, 2017 RFCR
NON-FINAL ACTION WRITTEN
Nov 13, 2017 CNRT
ASSIGNED TO EXAMINER
Nov 13, 2017 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 24, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 20, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 19, 2017 REPR